secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001493152-24-041885
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MangoRx Board initiates strategic alternatives review to maximize shareholder value
--------------------------------------------------------------------------------

- Formalized $150K promissory note with CEO's entity Cohen Enterprises at 8% interest, due Jan 2, 2025.
- Board formed strategy committee to explore mergers, acquisitions, divestitures, and business combinations.
- Process is in parallel with current operations; no timeline or assurance of any transaction.
- Company previously disclosed $50K loan from March 2024 and $100K loan from April 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224041885/0001493152-24-041885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315224041885/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer